During the last session, Bio-Path Holdings Inc (NASDAQ:BPTH)’s traded shares were 0.34 million, with the beta value of the company hitting 0.07. At the end of the trading day, the stock’s price was $1.16, reflecting an intraday gain of 0.87% or $0.01. The 52-week high for the BPTH share is $12.00, that puts it down -934.48 from that peak though still a striking 49.14% gain since the share price plummeted to a 52-week low of $0.59. The company’s market capitalization is $4.99M, and the average intraday trading volume over the past 10 days was 12.34 million shares, and the average trade volume was 3.14 million shares over the past three months.
Bio-Path Holdings Inc (BPTH) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. BPTH has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it.
Bio-Path Holdings Inc (NASDAQ:BPTH) trade information
Bio-Path Holdings Inc (BPTH) registered a 0.87% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 0.87% in intraday trading to $1.16, hitting a weekly high. The stock’s 5-day price performance is -14.07%, and it has moved by 63.38% in 30 days. Based on these gigs, the overall price performance for the year is -88.19%. The short interest in Bio-Path Holdings Inc (NASDAQ:BPTH) is 77764.0 shares and it means that shorts have 0.03 day(s) to cover.
Bio-Path Holdings Inc (BPTH) estimates and forecasts
Statistics show that Bio-Path Holdings Inc has outperformed its competitors in share price, compared to the industry in which it operates. Bio-Path Holdings Inc (BPTH) shares have gone down -32.16% during the last six months, with a year-to-date growth rate more than the industry average at 90.57% against 16.60.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 34.89%. While earnings are projected to return 90.57% in 2025.
BPTH Dividends
Bio-Path Holdings Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Bio-Path Holdings Inc (NASDAQ:BPTH)’s Major holders
Bio-Path Holdings Inc insiders own 0.04% of total outstanding shares while institutional holders control 1.08%, with the float percentage being 1.08%.
